help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2007-1288
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
149/5/2517    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Montaño, L. M.
Right arrow Articles by Perusquía, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montaño, L. M.
Right arrow Articles by Perusquía, M.
Endocrinology Vol. 149, No. 5 2517-2526
Copyright © 2008 by The Endocrine Society

Relaxation of Androgens on Rat Thoracic Aorta: Testosterone Concentration Dependent Agonist/Antagonist L-Type Ca2+ Channel Activity, and 5β-Dihydrotestosterone Restricted to L-Type Ca2+ Channel Blockade

Luis M. Montaño, Eduardo Calixto, Alejandra Figueroa, Edgar Flores-Soto, Verónica Carbajal and Mercedes Perusquía

Universidad Nacional Autónoma de México (M.P.), Instituto de Investigaciones Biomédicas, Departamento de Biología Celular y Fisiología, and Facultad de Medicina (L.M.M., A.F., E.F.-S.), Departamento de Farmacología, México D.F. 04510; Departamento de Hiperreactividad Bronquial (V.C.), Instituto Nacional de Enfermedades Respiratorias, México D.F. 14080; and Departamento de Neurobiología (E.C.), División de Investigación en Neurociencias, Instituto Nacional de Psiquiatria Ramón de la Fuente Muñíz, México D.F. 14370

Address all correspondence and requests for reprints to: Dr. Mercedes Perusquía, Apartado Postal 70228, México D.F. 04510. E-mail: perusqui{at}servidor.unam.mx.

Androgen vasorelaxing action is a subject of recent interest. We investigated the involvement of L-type voltage-operated Ca2+ channels (L-VOCCs), K+ channels, intracellular Ca2+ concentration ([Ca2+]i), and cAMP in the vasorelaxing effect of testosterone and 5β-dihydrotestosterone (5β-DHT) on rat thoracic aorta. Isolated aortic rings were used to study the vasorelaxing potency of testosterone and 5β-DHT on KCl- and noradrenaline-induced contractions. Patch-clamp was used to analyze androgen effects on Ca2+ inward and K+ outward currents. The fluorescence technique was used to evaluate [Ca2+]i in single myocytes; moreover, simultaneous measurements of [Ca2+]i and vascular contraction were evaluated. 5β-DHT was more potent than testosterone to relax KCl-induced contraction, but they were equipotent to relax noradrenaline contraction. L-type Ca2+ currents were blocked by nifedipine, both androgens, and an estrogen in a concentration-dependent manner, and the order of potency was: testosterone > nifedipine > 5β-DHT > 17β-estradiol. We observed that testosterone has different mechanism of action by the concentration range used: at nM concentrations it was a powerful L-VOCCs antagonist, whereas at µM concentrations it was observed that: 1) its Ca2+ antagonist property is reverted by increasing the L-type inward Ca2+ currents (Ca2+ agonist property); and 2) the [Ca2+]i and cAMP production was increased. The total K+ currents were unaffected by testosterone or 5β-DHT. The data show that 5β-DHT-induced vasorelaxation is due to its selective blockade on L-VOCCs (from nM to µM concentrations), but testosterone-induced vasorelaxation involves concentration-dependent additional mechanisms: acting as an L-VOCCs antagonist at low concentrations, and increasing [Ca2+]i and cAMP production at high concentrations.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society